Literature DB >> 21701261

The dynamic interplay between a PTK (Kit) and a PTP (Shp2) in hematopoietic stem and progenitor cells.

Helen He Zhu, Gen-Sheng Feng.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21701261      PMCID: PMC3322470          DOI: 10.4161/cc.10.14.15861

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


× No keyword cloud information.
  11 in total

Review 1.  The stem cell niches in bone.

Authors:  Tong Yin; Linheng Li
Journal:  J Clin Invest       Date:  2006-05       Impact factor: 14.808

Review 2.  The origins of the identification and isolation of hematopoietic stem cells, and their capability to induce donor-specific transplantation tolerance and treat autoimmune diseases.

Authors:  Irving L Weissman; Judith A Shizuru
Journal:  Blood       Date:  2008-11-01       Impact factor: 22.113

3.  Early transplantation to a normal microenvironment prevents the development of Steel hematopoietic stem cell defects.

Authors:  J E Barker
Journal:  Exp Hematol       Date:  1997-06       Impact factor: 3.084

4.  Hematopoietic stem cells proliferate until after birth and show a reversible phase-specific engraftment defect.

Authors:  Michelle B Bowie; Kristen D McKnight; David G Kent; Lindsay McCaffrey; Pamela A Hoodless; Connie J Eaves
Journal:  J Clin Invest       Date:  2006-10       Impact factor: 14.808

5.  The cellular basis of the genetically determined hemopoietic defect in anemic mice of genotype Sl-Sld.

Authors:  E A McCulloch; L Siminovitch; J E Till; E S Russell; S E Bernstein
Journal:  Blood       Date:  1965-10       Impact factor: 22.113

6.  PTPN11 is the first identified proto-oncogene that encodes a tyrosine phosphatase.

Authors:  Rebecca J Chan; Gen-Sheng Feng
Journal:  Blood       Date:  2006-10-19       Impact factor: 22.113

7.  Kit-Shp2-Kit signaling acts to maintain a functional hematopoietic stem and progenitor cell pool.

Authors:  Helen He Zhu; Kaihong Ji; Nazilla Alderson; Zhao He; Shuangwei Li; Wen Liu; Dong-Er Zhang; Linheng Li; Gen-Sheng Feng
Journal:  Blood       Date:  2011-03-30       Impact factor: 22.113

8.  Adverse prognostic significance of KIT mutations in adult acute myeloid leukemia with inv(16) and t(8;21): a Cancer and Leukemia Group B Study.

Authors:  Peter Paschka; Guido Marcucci; Amy S Ruppert; Krzysztof Mrózek; Hankui Chen; Rick A Kittles; Tamara Vukosavljevic; Danilo Perrotti; James W Vardiman; Andrew J Carroll; Jonathan E Kolitz; Richard A Larson; Clara D Bloomfield
Journal:  J Clin Oncol       Date:  2006-08-20       Impact factor: 44.544

9.  Essential role for Ptpn11 in survival of hematopoietic stem and progenitor cells.

Authors:  Gordon Chan; Laurene S Cheung; Wentian Yang; Michael Milyavsky; Ashley D Sanders; Shengqing Gu; Wan Xing Hong; Aurora X Liu; Xiaonan Wang; Mary Barbara; Tarun Sharma; Joehleen Gavin; Jeffery L Kutok; Norman N Iscove; Kevin M Shannon; John E Dick; Benjamin G Neel; Benjamin S Braun
Journal:  Blood       Date:  2011-02-25       Impact factor: 22.113

10.  Viable c-Kit(W/W) mutants reveal pivotal role for c-kit in the maintenance of lymphopoiesis.

Authors:  Claudia Waskow; Sabine Paul; Corinne Haller; Max Gassmann; Hans-Reimer Rodewald
Journal:  Immunity       Date:  2002-09       Impact factor: 31.745

View more
  3 in total

1.  Shp2 and Pten have antagonistic roles in myeloproliferation but cooperate to promote erythropoiesis in mammals.

Authors:  Helen He Zhu; Xiaolin Luo; Kaiqing Zhang; Jian Cui; Huifang Zhao; Zhongzhong Ji; Zhicheng Zhou; Jufang Yao; Lifan Zeng; Kaihong Ji; Wei-Qiang Gao; Zhong-Yin Zhang; Gen-Sheng Feng
Journal:  Proc Natl Acad Sci U S A       Date:  2015-10-12       Impact factor: 11.205

2.  Shp2 promotes metastasis of prostate cancer by attenuating the PAR3/PAR6/aPKC polarity protein complex and enhancing epithelial-to-mesenchymal transition.

Authors:  K Zhang; H Zhao; Z Ji; C Zhang; P Zhou; L Wang; Q Chen; J Wang; P Zhang; Z Chen; H H Zhu; W-Q Gao
Journal:  Oncogene       Date:  2015-06-08       Impact factor: 9.867

3.  SHP2 negatively regulates HLA-ABC and PD-L1 expression via STAT1 phosphorylation in prostate cancer cells.

Authors:  Zhuqing Liu; Yu Zhao; Juemin Fang; Ran Cui; Yuanyuan Xiao; Qing Xu
Journal:  Oncotarget       Date:  2017-06-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.